CellaVision AB (publ)
SSE:CEVI.ST
257 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | CellaVision AB (publ) |
Symbool | CEVI.ST |
Munteenheid | SEK |
Prijs | 257 |
Beurswaarde | 6,129,835,500 |
Dividendpercentage | 0.98% |
52-weken bereik | 120 - 275 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Simon Ostergaard |
Website | https://www.cellavision.com |
An error occurred while fetching data.
Over CellaVision AB (publ)
CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)